Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Ellipsis Health has developed an innovative care management platform powered by AI, featuring its virtual assistant, Sage, which aims to streamline and improve patient engagement through voice interactions that prioritize emotional intelligence while seamlessly fitting into existing clinical processes. Sage is capable of conducting completely autonomous phone conversations in multiple languages with patients, managing various tasks like enrolling in programs, verifying eligibility, checking copays, and responding to inquiries, in addition to carrying out assessments such as health risk evaluations, follow-up communications after discharge, satisfaction surveys, and tracking outcomes. This platform enhances clinical operations by facilitating care coordination, monitoring treatment adherence, and performing check-ins before and after discharges, thus aiding healthcare providers in ensuring uninterrupted care and boosting quality metrics. At the core of this system is an "empathy engine," which evaluates vocal biomarkers—such as tone, pace, and speech patterns—to identify emotional and mental health indicators, thereby providing valuable insights into patient wellbeing. Through these advanced capabilities, Sage not only assists in operational efficiency but also fosters a deeper connection between patients and healthcare practitioners, ultimately contributing to better health outcomes.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
No
API Access
Has API
No
Integrations
Signals Research Suite
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
Yes
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Ellipsis Health
Founded
2017
Country
United States
Website
ellipsishealth.com
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/